Editor's letter

Richard Jory

While you ponder yet another acronym for structured products - they are now Prips, or packaged retail investment products, according to the European Union - reflect upon the fact that there has been some kind of progress in the calamitous world of regulation. Nudging along slowly but surely, the EU has promised a new directive to further define the duty of care bestowed by the Markets in Financial Instruments Directive (Mifid).

The new offering of a horizontal directive was the most that could have been hoped for and has been welcomed by all of the many lobbying groups from Europe's now slightly diminished EUR8 trillion retail investment products industry. The promise is that there will be one code of practice that will prevail for the disclosure of information and the processes employed for the sale of investment to retail investors. Great. But, yet again, there is a blot on the landscape and, yet again, this lies in the implementation.

After a group hug in Brussels last May at an Open Hearing on retail investment products, there was a feeling that progress could be made. This promise of a new directive is progress, in principle, and advances have also been made in practice, with the EU finally accepting that Mifid should be a building block for any new rule. All of which is good. But then the EU lets itself down. It is fine to start with Mifid, and sensible to use the new directive to maybe provide more insight into the intended meaning of the terms 'appropriateness' and 'complex' - for which an Open Hearing was to be held under the aegis of the EU's independent Committee of European Securities Regulators (CESR) on June 5, as Structured Products went to press.

But then along comes the suggestion from the EU that the Level 2 and Level 3 implementation of the new horizontal directive could well be based on the consultation paper on technical issues relating to Key Information Document disclosures for Undertakings for Collective Investment in Transferable Securities published by CESR. That's all well and good if the principles relating to Ucits funds replicated the requirements of the structured products business. Sadly, they do not, so while we all luxuriate in the glow of some progress at the regional regulator level, loins need to be girded for the next round of bash the bureaucrat.

Richard Jory, richard.jory@incisivemedia.com, +44 (0)20 7484 9802.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here